Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
18.09
-0.82 (-4.34%)
At close: Oct 30, 2025, 4:00 PM EDT
18.02
-0.07 (-0.39%)
After-hours: Oct 30, 2025, 4:08 PM EDT

Oscar Health Stock Forecast

Stock Price Forecast

The 8 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $13.19, which forecasts a -27.09% decrease in the stock price over the next year. The lowest target is $11 and the highest is $17.

Price Target: $13.19 (-27.09%)
Analyst Consensus: Sell
TargetLowAverageMedianHigh
Price$11$13.19$13.5$17
Change-39.19%-27.09%-25.37%-6.03%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy000000
Buy311000
Hold321223
Sell224444
Strong Sell001111
Total857778

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Hold
Initiates
$17
HoldInitiates$17-6.03%Oct 14, 2025
Wells Fargo
Wells Fargo
Sell
Maintains
$10$14
SellMaintains$10$14-22.61%Oct 7, 2025
Piper Sandler
Piper Sandler
Hold
Maintains
$14$13
HoldMaintains$14$13-28.14%Aug 14, 2025
Baird
Baird
Hold
Downgrades
$28$14
HoldDowngrades$28$14-22.61%Jul 25, 2025
Barclays
Barclays
Sell
Maintains
$17$11
SellMaintains$17$11-39.19%Jul 23, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
12.28B
from 9.18B
Increased by 33.80%
Revenue Next Year
11.56B
from 12.28B
Decreased by -5.84%
EPS This Year
-1.47
from 0.10
EPS Next Year
-0.43
from -1.47
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
390.99M1.89B3.96B5.86B9.18B12.28B11.56B
Revenue Growth
-17.79%384.43%109.27%47.92%56.54%33.80%-5.84%
EPS
-14.16-3.20-2.85-1.220.10-1.47-0.43
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High12.7B12.7B
Avg12.3B11.6B
Low11.7B10.7B

Revenue Growth

Revenue Growth202520262027
High
38.6%
3.7%
Avg
33.8%
-5.8%
Low
27.2%
-13.0%

EPS Forecast

EPS202520262027
High-1.230.17
Avg-1.47-0.43
Low-1.87-1.04

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.